⌘K

Home/Filings/4/0001140361-17-047234

4//SEC Filing

Chan Kin Foong 4

Accession 0001140361-17-047234

CIK 0001504167other

View on SEC.gov Company Profile

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 5:55 PM ET

Size

7.3 KB

Accession

0001140361-17-047234

Insider Transaction Report

Form 4

Period: 2017-12-20

BioPharmX CorpBPMX

10% Owner

Transactions

Award
Employee Stock Option (right to buy)
2017-12-20+414,000→ 414,000 total
Exercise: $0.20Exp: 2027-12-20→ Common Stock (414,000 underlying)
Award
Employee Stock Option (right to buy)
2017-12-20+900,000→ 900,000 total
Exercise: $0.10Exp: 2027-12-20→ Common Stock (900,000 underlying)

Footnotes (1)

[F1]The option vests and becomes exercisable ratably over 36 months

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

BioPharmX Corp

CIK 0001504167

Entity typeother

Related Parties

1

filerCIK 0001599238

Filing Metadata

Form type: 4
Filed: Dec 21, 7:00 PM ET
Accepted: Dec 22, 5:55 PM ET
Size: 7.3 KB

View on SEC.gov